Ricerca
Ricoveri per nove malattie prevenibili con la vaccinazione
Hospital admissions for 9 vaccine preventable diseases: the case of Friuli Venezia Giulia
R. Tominz, F. Valent, G. Candini, T. Gallo
Maggio 2016 - pagg. 303 -309
Abstract
Background - Despite the overall success of vaccines, demonstrated by the drastic reduction
in the incidence of diseases preventable by vaccination a few years after the vaccination
campaigns started, vaccination rates remain low, also because of a broad disinformation.
Often, those who hinder vaccination argue that infectious diseases of childhood
are no longer dangerous.
Objectives - This paper aims to provide health professionals with statistical objective information on the risks of these diseases in the population of an Italian region.
Materials and methods - Between 1986 and 2014 the Health Information System of Friuli Venezia Giulia allowed the identification of all hospital admissions for measles, mumps, whooping cough, rubella, tetanus, chicken pox and haemophilus, meningococcal and pneumococcal diseases.
Results - The number of cases detected in the 29 years of study varies from a maximum of 3,527 for pneumococcal diseases to a minimum of 82 for tetanus, out of a population of just over 1.2 million inhabitants, with a total of 798 deaths at discharge mostly, but not exclusively, in elderly people.
Conclusions - These diseases then exist and can be severe enough to lead to hospitalization and sometimes even death.
Objectives - This paper aims to provide health professionals with statistical objective information on the risks of these diseases in the population of an Italian region.
Materials and methods - Between 1986 and 2014 the Health Information System of Friuli Venezia Giulia allowed the identification of all hospital admissions for measles, mumps, whooping cough, rubella, tetanus, chicken pox and haemophilus, meningococcal and pneumococcal diseases.
Results - The number of cases detected in the 29 years of study varies from a maximum of 3,527 for pneumococcal diseases to a minimum of 82 for tetanus, out of a population of just over 1.2 million inhabitants, with a total of 798 deaths at discharge mostly, but not exclusively, in elderly people.
Conclusions - These diseases then exist and can be severe enough to lead to hospitalization and sometimes even death.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. World Health Organization (WHO). European
Vaccine Action Plan 2015-2020. http://
www.euro.who.int/en/health-topics/ diseaseprevention/
vaccines-and-immunization/publications/
2014/european-vaccine-action-plan-
20152020.
2. World Health Organization (WHO), UNICEF,
The World Bank. State of the world’s vaccines
and immunization; 3rd edition. Geneva,
World Health Organization, 2009. http://apps.
who.int/iris/bitstream/10665/44169/
1/9789241563864_eng.pdf.
3. Centers for Disease Control and Prevention.
Epidemiology and Prevention of Vaccine-
Preventable Diseases. Impact of vaccines in
the 20th and 21st Centuries. http://www.cdc.
gov/vaccines/pubs/pinkbook/downloads/appendices/
E/impact.pdf.
4. Rapporto Meridiano Sanità 2014. http://
www.ambrosetticlub.eu/ricerche/altre-ricerche-
ambrosetti/item/9157-rapporto-finale-meridiano-
sanit%C3%A0-2014.
5. Signorelli C. La vera eccellenza dei vaccini e i
falsi miti da sfatare. Epidemiol Prev 2015;39
(3):198-201.
6. Tozzi AE, Ciofi degli Atti ML. Prevenire la pertosse.
Rivista di Immunologia e Allergologia Pediatrica
2010;02:42-8. http://www.siaip. it/upload/
riap/360_prevenire%20la%20pertosse.pdf.
7. Bardelle G, Baldo V. Malattie invasive da Haemophilus
B. Società Italiana d’Igiene Medicina
Preventiva e Sanità Pubblica. Aprile 2013. http:
//www.vaccinarsi.org/malattie-prevenibili/malattie-
invasive-hib.html.
8. Durando, P, Crovari P, Ansaldi F, et al.; Collaborative
Group for Pneumococcal Vaccination
in Liguria. Universal childhood immunisation
against Streptococcus pneumoniae: the five-year
experience of Liguria Region, Italy. Vaccine
2009;27(25-26):3459-62.
9. Dagan R. Impact of pneumococcal conjugate
vaccine on infections caused by antibiotic-resistant
Streptococcus pneumoniae. Journal Compilation.
European Society of Clinical Microbiology
and Infectious Diseases, CMI, 2009;15
(Suppl. 3):16-20.
10. Gabutti G, Azzari C, Bonanni P, et al. La vaccinazione
universale contro la varicella in Italia:
una questione di equità. Ig Sanità Pubbl 2015;71:
115-27.
11. Ministero della Salute Direzione Generale
della Programmazione Sanitaria – Ufficio VI
Adempimento “mantenimento dell’erogazione
dei LEA” attraverso gli indicatori della Griglia
Lea. Metodologia e Risultati dell’anno 2013.
http://www.salute.gov.it/imgs/C_17_ pubblicazioni_
2397_allegato.pdf.
12. Delibera di Giunta Regionale n. 2535 del
18.12.2014. Aggiornamento ed estensione dell’offerta
vaccinale nella Regione Friuli Venezia
Giulia. http://www.regione.fvg.it/asp/delibere/
layout1.asp.
13. Ministero della Salute. Banca dati ricoveri
ospedalieri SDO. http://www.salute.gov.it/ portale/
temi/ric_codice/default.jsp.
14. Coperture vaccinali nell’infanzia e nell’adolescenza
in Friuli Venezia Giulia. Aggiornamento
luglio 2015. http://www.regione.fvg.it/rafvg/
cms/RAFVG/salute-sociale/promozione-saluteprevenzione/
FOGLIA5/.
15. Boehmer TK, Patnaik JL, Burnite SJ, Ghosh
TS, Gershman K, Vogt RL. Use of hospital discharge
data to evaluate notifiable disease reporting
to Colorado’s Electronic Disease Reporting
System. Public Health Rep 2011;
126(1):100-6.
16. Haslam N, Hoang U, Goldacre MJ. Trends in
hospital admission rates for whooping cough in
England across five decades: database studies. J
R Soc Med 2014;107(4):157-62.
17. Gowin E, Wysocki J, Michalak M. Don’t forget
how severe varicella can be-complications
of varicella in children in a defined Polish population.
Int J Infect Dis 2013;17(7):e485-9.
18. Reynolds MA, Watson BM, Plott-Adams KK,
et al. Epidemiology of varicella hospitalizations
in the United States, 1995-2005. J Infect Dis
2008;197 Suppl 2:S120-6.
19. Goldacre MJ, Maisonneuve JJ. Hospital admission
rates for measles and mumps in England:
historical perspective. Lancet 2013;382
(9889):308-9.
20. Sizaire V, Garrido-Estepa M, Masa-Calles J,
Martinez de Aragon MV. Increase of pertussis
incidence in 2010 to 2012 after 12 years of low
circulation in Spain. Euro Surveill 2014;19(32).
21. Braida C, Gallo T. Coperture vaccinali nell’infanzia
e nell’adolescenza in Friuli Venezia
Giulia. http://www.regione.fvg.it/rafvg/export/
sites/default/RAFVG/salute-sociale/p
romozione-salute-prevenzione/FOGLIA5/allegati/
20012015_2013_FVG_Report_Coperture_
vaccinali.pdf.
22. Tominz R, Mazzoleni B, Michieletto F, Perosa
P. Conoscenza, attitudini e pratica dei genitori
nei confronti delle vaccinazioni dell’infanzia
a Trieste. Medico e Bambino, Pagine
elettroniche maggio 2003. http://www.medicoebambino.
com/?id=RI0305_10.html.
23. Fine P, Eames K, Heymann DL. “Herd immunity”:
a rough guide. Clin Infect Dis 2011;
52(7):911-6.
24. Cole P. The moral bases for public health
interventions. Epidemiology 1995;6(1):78-83.
Corrispondenza: riccardo.tominz@aas1.sanita.fvg.it